Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatotoxicity”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Large-scale testing (Phase 3)Ended earlyNCT01118663
What this trial is testing

Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection

Who this might be right for
Acetaminophen Overdose
Cumberland Pharmaceuticals 17
Not applicableUnknownNCT02588560
What this trial is testing

Viral Load Changes in Lymphoma Patients With HCV Infection After Chemotherapy

Who this might be right for
LymphomaHepatitis C AntibodiesDrug Therapy
Chang Gung Memorial Hospital 38
Not applicableStudy completedNCT04022525
What this trial is testing

Assessment of Leflunomide Efficacy and Hepatotoxicity in Patients With Rheumatoid Arthritis Through Pharmacokinetic and Genetic Approaches

Who this might be right for
Rheumatoid Arthritis
Assiut University 80
Post-approval studies (Phase 4)UnknownNCT00728546
What this trial is testing

NAT2 in Re-challenge of INH in Patients With Hepatitis

Who this might be right for
TuberculosisHepatotoxicity
National Taiwan University Hospital 100
Post-approval studies (Phase 4)Study completedNCT03302299
What this trial is testing

Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT)

Who this might be right for
TuberculosisHIV/AIDSAlcohol Abuse
University of California, San Francisco 302
Not applicableUnknownNCT02076685
What this trial is testing

NAT2 Genotyping in Re-challenge Protocol of INH Titration in Patients With Anti-TB Medications-induced Hepatitis

Who this might be right for
Hepatotoxicity
National Taiwan University Hospital 60
Not applicableStudy completedNCT03327740
What this trial is testing

PRJ2203: Dolutegravir Post Authorization Safety Study (PASS)

Who this might be right for
Infection, Human Immunodeficiency Virus I
ViiV Healthcare 1
Not applicableLooking for participantsNCT06649474
What this trial is testing

Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1

Who this might be right for
Pancreatic CancerResectable Pancreatic AdenocarcinomaAdenocarcinoma+3 more
University Hospital, Clermont-Ferrand 100
Not applicableStudy completedNCT03833297
What this trial is testing

Monitoring the HePAtological TOXicity of Drugs (HePATOX)

Who this might be right for
Liver DiseasesLiver DysfunctionLiver Failure+1 more
Groupe Hospitalier Pitie-Salpetriere 1,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06251232
What this trial is testing

Proof-of-concept to Evaluate the Efficacy and Safety of Prednisone in Idiosyncratic Hepatotoxicity

Who this might be right for
HepatotoxicityIdiosyncratic Drug EffectPrednisone
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 60
Not applicableLooking for participantsNCT03568266
What this trial is testing

Pharmacogenomics of Asparaginase Induced Hepatotoxicity

Who this might be right for
Acute Lymphoblastic Leukemia
University of Southern California 500
Post-approval studies (Phase 4)Study completedNCT00405301
What this trial is testing

Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage

Who this might be right for
Drug Induced HepatotoxicityTuberculosis
All India Institute of Medical Sciences 175
Not applicableStudy completedNCT00137059
What this trial is testing

Acetaminophen-induced Hepatotoxicity in Chronic Alcohol Abusers

Who this might be right for
Hepatotoxicity
Dr. Marco L.A. Sivilotti 40
Not applicableLooking for participantsNCT04476563
What this trial is testing

Checkpoint Inhibitor-induced Liver Injury

Who this might be right for
Immune-Mediated Hepatitis
University of Nottingham 160
Testing effectiveness (Phase 2)Ended earlyNCT02859415
What this trial is testing

Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases

Who this might be right for
Esophageal NeoplasmsLung NeoplasmsMesothelioma+2 more
National Cancer Institute (NCI) 3
Early research (Phase 1)Study completedNCT00489385
What this trial is testing

An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals

Who this might be right for
HIV InfectionsHCV
National Institute of Allergy and Infectious Diseases (NIAID) 41
Not applicableLooking for participantsNCT04635111
What this trial is testing

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

Who this might be right for
HepatotoxicityTenosynovial Giant Cell Tumor
Daiichi Sankyo 30
Post-approval studies (Phase 4)UnknownNCT02889757
What this trial is testing

The Protective Effect for Liver Organ in Patients With Anti-TB Drugs Using of Acetylcysteine (NAC)

Who this might be right for
Protective Effect in TB-DIHTB-DIH Means: Drug Induced Liver Function Abnormalities
Far Eastern Memorial Hospital 400
Not applicableUnknownNCT05430126
What this trial is testing

Hepatotoxicity Related to Protein Kinase Inhibitors

Who this might be right for
Cancer
Central South University 600,000
Post-approval studies (Phase 4)Study completedNCT00537771
What this trial is testing

Liver Safety Under Upfront Arimidex vs Tamoxifen

Who this might be right for
Breast Cancer
AstraZeneca 384
Next Page